Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

9.790 -0.180 (-1.81%)
Streaming Delayed Price Updated: 1:04 PM EST, Feb 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NeoGenomics, Inc. - Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Big Developments Set to be Unveiled at This Year’s San Antonio Breast Cancer Symposium (SABCS)
EQNX::TICKER_START (NASDAQ:ONCY),(NYSE:LLY),(NASDAQ:NEO),(NYSE:ZYME),(NASDAQ:GTHX) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
RaDaR(R) Assay Demonstrates Clinical Potential for Detecting Disease Recurrence Across All Types of Early Breast Cancer, Including Triple Negative Disease
Via ACCESSWIRE
News headline image
NeoGenomics and ImmunoGen Launch New Program Giving Ovarian Cancer Patients Access to Novel FR Biomarker Testing to Support the Launch of ELAHERE(TM)
Via ACCESSWIRE
News headline image
BrightView Holdings, America's Car-Mart And Some Other Big Stocks Moving Lower On Thursday ↗
U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Thursday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Why Shares of NeoGenomics Jumped 53.9% This Week ↗
The cancer screening company showed its turnaround may be working. 
Via The Motley Fool
News headline image
Where NeoGenomics Stands With Analysts ↗
Within the last quarter, NeoGenomics (NASDAQ:NEO) has observed the following analyst ratings: 
Via Benzinga
News headline image
NeoGenomics Reports Third Quarter 2022 Results
Via ACCESSWIRE
News headline image
NVIDIA To $225? Plus Raymond James Cuts PT On This Stock By 81% ↗
Oppenheimer cut the price target on NVIDIA Corporation (NASDAQ: NVDA) from $250 to $225. Oppenheimer analyst Rick Schafer maintained an Outperform rating on the stock. NVIDIA shares rose 0.9% to... 
Via Benzinga
News headline image
Earnings Scheduled For November 11, 2022 ↗
Companies Reporting Before The Bell • Dingdong (Cayman) (NYSE:DDL) is expected to report quarterly loss at $0.37 per share on revenue of $919.90 million. 
Via Benzinga
News headline image
DuPont, Expeditors International, Planet Fitness And Other Big Gainers From Tuesday ↗
U.S. stocks closed higher on Tuesday, with the Dow Jones surging more than 300 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  Thursday saw 177 companies set new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  On Wednesday, 200 companies hit new 52-week lows. 
Via Benzinga
News headline image
NeoGenomics and Liquid Biopsy Subsidiary Inivata and Collaborators to Present New Data at ESMO Congress 2022
Via ACCESSWIRE
News headline image
Turnaround For This Cancer Genetics Testing Firm Could Take Years, Analyst Says While Downgrading Stock ↗
 
Via Benzinga
News headline image
Why Party City Holdco Shares Tumbled Over 40%; Here Are 98 Biggest Movers From Yesterday ↗
Gainers Unique Fabricating, Inc. (NYSE: UFAB) jumped 56.3% to close at $0.8205 on Tuesday. Unique Fabricating posted a Q3 loss of $0.90 per share after the closing bell on Tuesday. 
Via Benzinga
News headline image
NeoGenomics: Q2 Earnings Insights ↗
  NeoGenomics (NASDAQ:NEO) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers 
Via Benzinga
News headline image
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast... 
Via Benzinga
News headline image
NeoGenomics Appoints David Perez, Industry Veteran and Former Terumo BCT CEO, to Its Board of Directors
Via ACCESSWIRE
News headline image
If You Invested $1,000 In These 3 Crypto Tokens You Would Have This Much In Crypto Dividends ↗
When navigating the cryptocurrency market it can be difficult to distinguish between the “s— tokens” and tokens that actually provide value through a utility. 
Via Benzinga
News headline image
NeoGenomics Provides Update on MolDX Submission for CRC and RaDaR(TM) Commercial Launch
Via ACCESSWIRE
News headline image
Aaron's, Celestica, Medpace Holdings And Some Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday ↗
Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company. 
Via Benzinga
News headline image
Starbucks Plunges As Xi Jinping Consolidates Power: Here's What's Going On ↗
Starbucks Corporation (NASDAQ: SBUX) was sliding about 6% lower on Monday in tandem with a number of China-based stocks. 
Via Benzinga
News headline image
NeoGenomics Schedules its Third Quarter 2022 Earnings Release for November 8, 2022
Via ACCESSWIRE
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Target To $200? Here Are 5 Other Price Target Changes For Thursday ↗
Raymond James raised the price target on Target Corporation (NYSE: TGT) from $190 to $200. However, Raymond James analyst Bobby Griffin maintained the stock with a Strong Buy. Target shares fell 0.1%... 
Via Benzinga
News headline image
NeoGenomics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Via ACCESSWIRE
News headline image
Earnings Scheduled For August 12, 2022 ↗
Companies Reporting Before The Bell • NeoGenomics (NASDAQ:NEO) is projected to report quarterly earnings at $0.44 per share on revenue of $218.26 million. 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.